Real-time enrollment status for this thyroid eye disease, ted clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 4:10 PM UTC
| NCT Number | NCT07622108 |
| Recruiting Status | Recruiting |
| Condition | Thyroid Eye Disease, TED |
| Phase | PHASE3 |
| Target Enrollment | 84 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Minghui Pharmaceutical (Hangzhou) Ltd |
| Last Updated on CT.gov | October 14, 2026 (5 days ago) |
As of October 19, 2026: Clinical trial NCT07622108 is currently recruiting participants. This phase3 study for thyroid eye disease, ted is actively seeking new participants at 1 location across the United States. The study is sponsored by Minghui Pharmaceutical (Hangzhou) Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07622108 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07622108 was last updated 5 days ago (October 14, 2026). HelloStudys verifies this status automatically.